Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NC › Plymouth › NPI 1124018494
Hospital

Cah Acquisition Company 1 LLC

Cah Acquisition Company 1 LLC was paid $709K by Medicaid between Jan 2018 and Jul 2022, across 23 billing codes. Its largest line is 99283, emergency room visit (moderate) — 29% of everything it billed.

33Billing provider infoCAH ACQUISITION COMPANY 1 LLC
PLYMOUTH, NC 27962
33aNPI1124018494assigned 10/26/2005
33bProvider typeCritical Access Hospital
28Total paid$709K
24GClaims10,270
24DCodes billed23
24AFirst – last monthJan 2018 – Jul 2022
Compared with peers

Next to other Critical Access Hospital providers in North Carolina

Rank by total paid#17 of 25
Median peer was paid$1.32M
This provider vs. median0.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K$60K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20183,283$320K
20191,980$99K
20201,719$100K
20212,835$151K
2022453$39K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 29% 1,632 1,371 $208K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 29% 694 573 $206K
99282 Emergency department visit for the evaluation and management, low to moderate severity 24% 2,072 1,704 $168K
86328 4.3% 767 676 $31K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 4.3% 922 667 $30K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 2.1% 301 268 $15K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1.4% 375 316 $10K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 1.4% 226 183 $10K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1.1% 303 274 $8K
80053 Comprehensive metabolic panel <1% 630 510 $6K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 207 174 $5K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 587 458 $4K
11 more codes
36415 Collection of venous blood by venipuncture <1% 968 $3K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 63 $2K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 14 $905.81
87400 <1% 130 $656.88
81001 <1% 223 $639.53
87420 <1% 13 $584.66
80061 Lipid panel <1% 46 $540.40
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 33 $404.17
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 37 $271.32
87086 Culture, bacterial; quantitative colony count, urine <1% 14 $110.55
83036 Hemoglobin; glycosylated (A1C) <1% 13 $96.72

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialAVIGNONE, FRANK (CEO)
Parent organizationCAH ACQUISITION COMPANY 1 LLC
Same official

Other billing entities under AVIGNONE, FRANK

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.